Oncolytics Biotech is seeking accelerated approval for its lead cancer therapy, pelareorep, with plans to start a ...

Transgene’s therapeutic vaccine candidate TG4001 has flunked a phase 2 solid tumor trial. But, while the prospect failed to ...

Virus is associated with sickness, but oncolytic virus therapies, which harness viruses to attack and kill cancer cells, may soon change the standard of treatment for cancer, including those long ...

KaliVir Immunotherapeutics has dosed the first subject in a Phase I/Ib clinical trial for its new oncolytic immunotherapy, ...

CLD-101 is a novel stem cell-based treatment that delivers oncolytic viruses to tumors, which may benefit patients with newly ...

Germany-based Merck KGaA has announced the launch of a new €290m ($317.6m) biosafety testing facility in Rockville, Maryland, ...

UP Oncolytics Inc. has been awarded an NIH fast track grant to support the development of a treatment for glioblastoma using oncolytic Zika virus.

Trial will evaluate multiple doses of CLD-101 for the treatment of newly diagnosed high-grade gliomaCLD-101 is Calidi’s novel allogeneic ...

WOBURN, Mass., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...

SK bioscience completed the acquisition of German CDMO company IDT Biologika with over a century of history that enables ...

Analysts have set 12-month price targets for ANI Pharmaceuticals, revealing an average target of $79.8, a high estimate of ...